SIERRA MAHONEY: Open Payments
NPI 1316691223 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,962 in 127 payments from 22 companies in 2025. Trend: 2023 $2,171 · 2024 $3,148 · 2025 $4,962
Food & beverage: $3,262Consulting: $1,595Education: $105
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,595 |
| UCB, Inc. | 18 | $541 |
| Janssen Biotech, Inc. | 14 | $500 |
| Regeneron Healthcare Solutions, Inc. | 9 | $320 |
| Galderma Laboratories, L.P. | 14 | $274 |
| ABBVIE INC. | 12 | $219 |
| Organon LLC | 7 | $214 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $208 |
| Amgen Inc. | 6 | $201 |
| LEO Pharma Inc. | 10 | $146 |
Products named: TREMFYA, Bimzelx, DUPIXENT, NEMLUVIO, ILUMYA, SKYRIZI, VTAMA, SOFDRA.
Industry payments across FL — which companies pay providers there.
